Li Dengyu, Zhang Kaiqin, Xue Xiaofeng, Bai Zhanchun, Yang La, Qi Jingjing, Suolang Sizhu
College of Animal Science, Tibet Agricultural and Animal Husbandry University, Nyingchi 860000, China.
Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences China, Shanghai 200241, China.
Animals (Basel). 2025 Mar 6;15(5):755. doi: 10.3390/ani15050755.
This study aimed to evaluate the therapeutic effect of (TC) on Tibetan yak-origin -induced diarrhea and dysentery in mice. The levels of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, and TNF-α), anti-inflammatory cytokines (IL-4 and IL-10), and the oxidative stress markers malondialdehyde (MDA), superoxide dismutase (T-SOD), total antioxidant capacity (T-AOC), reduced glutathione (GSH-PX), and catalase (CAT) in the serum of mice were measured using ELISA kits. Using microbial diversity sequencing and non-targeted metabolomics detection techniques, the relevant mechanisms of TC treatment in a mouse infection model were evaluated. The results showed the following: TC can effectively reduce the diarrhea rate; alleviate weight loss caused by invasion; reduce the pro-inflammatory cytokines IL-1β, IL-6, IL-8, and TNF-α in serum; and increase the concentrations of the anti-inflammatory cytokines IL-4 and IL-10. TC can improve the body's antioxidant levels to heal the damage caused by oxidative stress and lipid peroxidation. The histological section results show that TC can significantly improve gastric and intestinal tissue lesions and has no toxic effects on the liver and kidneys. 16S rRNA and ITS sequencing analysis suggests that , , (bacterial community), , , and (fungal community) may be key functional microbial communities in TC. Non-targeted metabolomics also suggests that the antibacterial treatment of dysentery with chebulic acid may be related to regulation of the Ras signaling pathway, long-term potentiation, the MAPK signaling pathway, metabolic pathways, and gut microbiome composition. Conclusion: TC has clear clinical efficacy in treating bacterial diarrhea, presenting anti-inflammatory and antioxidant effects. Its roles in regulating the gut microbiome and metabolic pathways and products were determined as the main reason for its therapeutic effect in a mouse gastroenteritis model caused by infection.
本研究旨在评估(TC)对小鼠藏牦牛源引起的腹泻和痢疾的治疗效果。使用酶联免疫吸附测定试剂盒测量小鼠血清中促炎细胞因子(IL-1β、IL-6、IL-8和TNF-α)、抗炎细胞因子(IL-4和IL-10)以及氧化应激标志物丙二醛(MDA)、超氧化物歧化酶(T-SOD)、总抗氧化能力(T-AOC)、还原型谷胱甘肽(GSH-PX)和过氧化氢酶(CAT)的水平。采用微生物多样性测序和非靶向代谢组学检测技术,评估TC治疗在小鼠感染模型中的相关机制。结果如下:TC可有效降低腹泻率;减轻侵袭引起的体重减轻;降低血清中促炎细胞因子IL-1β、IL-6、IL-8和TNF-α的水平;并增加抗炎细胞因子IL-4和IL-10的浓度。TC可提高机体抗氧化水平,以修复氧化应激和脂质过氧化造成的损伤。组织学切片结果表明,TC可显著改善胃肠组织损伤,且对肝脏和肾脏无毒性作用。16S rRNA和ITS测序分析表明,(细菌群落)、(细菌群落)、(细菌群落)以及(真菌群落)、(真菌群落)和(真菌群落)可能是TC中的关键功能微生物群落。非靶向代谢组学还表明,诃子酸治疗痢疾的抗菌作用可能与Ras信号通路、长时程增强、丝裂原活化蛋白激酶信号通路、代谢途径和肠道微生物群组成的调节有关。结论:TC在治疗细菌性腹泻方面具有明确的临床疗效,具有抗炎和抗氧化作用。其在调节肠道微生物群以及代谢途径和产物方面的作用被确定为其在感染引起的小鼠肠胃炎模型中发挥治疗作用的主要原因。